MWG-Biotech enters cancer research cooperation with scientists from the University of Würzburg
Helicobacter hepaticus, a member of the Enterohepatic Helicobacter Species (EHS) causes chronic active hepatitis, liver cancer and inflammatory bowel disease (IBD) in mice. Research evidence has linked EHS to human diseases, such as chronic cholecystitis and liver cancer. Helicobacter hepaticus is a close relative of the human gastric pathogen Helicobacter pylori, which is held responsible for causing stomach cancer. A comparative analysis of the genome sequences of H. hepaticus and H. pylori is expected to provide valuable insight into the pathogenic (disease-causing) mechanisms of bacteria to promote chronic infection, inflammation and malignant diseases like cancer.
„This cooperation makes full use of our knowhow and our synergistic competence profile that enables us to offer every service on the road from genome to gene function“ says Michael Weichselgartner, CEO of MWG-Biotech. „We are especially proud that scientists of high renown like Prof. Suerbaum and Prof. Fox have chosen MWG as a partner in their research work, and it is a pleasure for us to have GeneData, one of the leaders in functional genomics with a proven record in anti-bacterial target identification, as part of the team. We expect valuable insight for cancer research and the pharmaceutical industry to come from this project.“
The production of the shotgun libraries and sequencing will take place at MWG. Annotation will be performed by MWG with their proprietary bioinformatics platform BioGist™. Functional annotation and comparative genome characterization will be carried out using the GeneData Phylosopher™ software system, and will also include a full genome comparison of H. hepaticus and H. pylori. The annotation will be completed and analyzed for clues to carcinogenic mechanisms by Prof. Suerbaum of the University of Würzburg and Prof. Fox of the M.I.T.. Subsequent experiments in their laboratories will be performed to validate the conclusions raised from the sequence data.
„This collaboration with two of the leading scientists in the Helicobacter field and with MWG-Biotech’s rapid sequencing facility, shows the applicability of GeneData Phylosopher™ to cancer related questions“ states Othmar Pfannes, GeneData’s CEO. „Our state-of-the-art genome analysis system is successfully used by pharmaceutical companies to develop new antibiotics. Now we show GeneData Phylosopher™‘s capabilities in another area of important research.“
From the research results MWG will design and produce a Helicobacter hepaticus microarray for the identification of target genes for diagnostic and therapeutic purposes. Both Prof. Suerbaum and Prof. Fox, together with their teams at the Institute of Hygiene and Microbiology in Würzburg and the Division of Comparative Medicine at the Massachusetts Institute of Technology in Cambridge, MA, USA, have performed acclaimed and highly-cited research work on the pathogenesis of Helicobacter pylori and related bacteria for more than ten years. Prof. Fox and Prof. Suerbaum have performed successful collaborative research projects together for many years. "Helicobacter hepaticus is the paradigm organism for the enterohepatic Helicobacter species, which have pathogenic potential in humans and animals", says Prof. Fox. "MWG Biotech and GeneData's expertise in genomic-scale sequencing, sequen
Most read news
Other news from the department science
These products might interest you
Systec H-Series by Systec
Safe, reproducible and validatable sterilization of liquids, solids and waste
Autoclaves with 65-1580 liters usable space, flexibly expandable for various applications
Gilson MyPIPETMAN Select and MyPIPETMAN Enterprise Pipettes by Gilson
Grab the Gilson pipettes with your name and favorite colors!
Customise Your Pipettes to Fit Your Research
Whatman™ folded filter papers by Cytiva
Whatman folded filter papers
Convenient folded formats speed up your sample preparation
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.